Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Current Front-line Treatment for Metastatic Breast Cancer
Link ID 2891
Title Current Front-line Treatment for Metastatic Breast Cancer
Url http://www.medscape.com/viewarticle/569481?src=rss
Description In this SABCS 2007 summary, Dr. Kathy D. Miller discusses results of a number of studies that may influence treatment decisions for women with metastatic breast cancer.
Category Articles > Hematology-Oncology
Keywords
Date Feb 1, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Myelodysplastic Syndromes: Understanding the Biology, Pursuing New Treatments
  Advances in understanding the biology of myelodysplastic syndromes and the role of new and emerging treatment options are reviewed in this summary from ASH 2007.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. Evolving Role of mTOR Inhibition in the Treatment of Renal Cell Carcinoma: An Expert Interview With
  In this Expert Interview from ASCO 2008, Dr. Robert Motzer discusses the evolving role of mTOR inhibition in the treatment of renal cell carcinoma, with a focus on the newest agent in the class.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. Long-Term Data Confirm Rituximab Plus Chemo in Follicular Lymphoma
  Long-term data confirm the benefits of adding rituximab to chemotherapy in the first-line treatment of follicular lymphoma. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. ESAs Should Continue to be Used for Anemia in Cancer Patients, Says FDA Advisory Committee
  Erythropoiesis-stimulating agents should continue to have an oncology indication, even though questions about their safety remain. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Tamoxifen Superior to Arzoxifene for Locally Advanced or Metastatic Breast Cancer
  Compared with arzoxifene, tamoxifen provides longer progression-free survival and time to treatment failure in women with locally advanced and metastatic breast cancer, according to a report in the November 1st Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS